Pulmonary myeloid cell uptake of biodegradable nanoparticles conjugated with an anti-fibrotic agent provides a novel strategy for treating chronic allergic airways disease
Amlan Chakraborty, Anita A. Pinar, Maggie Lam, Jane E. Bourke, Simon G. Royce, Cordelia Selomulya, Chrishan S. Samuel
Topics & Concepts
MedicineMyofibroblastInflammationPharmacologyNasal administrationDrug deliveryImmunologyFibrosisPathologyMaterials scienceNanotechnologyPregnancy-related medical researchPreterm Birth and ChorioamnionitisNeonatal Respiratory Health Research